MedTrace Logo

OncoSweep Cancer Spotlight and Spectrum Product Line

NCT06261294 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2025-09-17

No results posted yet for this study

Summary

CONQUER cancer study: To collect blood samples from cancer and non-cancer participants for development and validation of the 'OncoSweep Cancer Spotlight and Spectrum Product Line'

Conditions

Interventions

DIAGNOSTIC_TEST

OncoSweep Lung Spotligh

This study is to develop and validate the performance of OncoSweep Lung Spotlight for detecting circulating miRNA expression, ctDNA methylation status, platelet RNA, and tumor marker expressions by utilizing real-time polymerase chain reaction (qPCR). The method is to collect venous blood from subjects during their routine visit to the healthcare facilities.

Sponsors & Collaborators

  • Pharus Taiwan, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-29
Primary Completion
2025-03-03
Completion
2025-05-07

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06261294 on ClinicalTrials.gov